Subcutaneous Immunoglobulin for CIDP

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
The investigators are using self administered subcutaneous IG in patients with CIDP who require IVIG. Safety, efficacy, and patient satisfaction will be examined.
Epistemonikos ID: fe7b1cfdd05076b7bc9c45f96f7cd8242e1aae49
First added on: May 12, 2024